found that checkpoint molecules of PD-1, Tim-3 and LAG-3 were not persistently upregulated on CD4+ and CD8+ T cells after anti-BCMA BiTE® AMG 701 treatment in MM cells [24]. Here, CD8A is linked to Miyoshi myopathy.